Reassessing the Generics Strategy

Leah Hoffmann

The head of strategy at an animal health company was facilitating a global strategy refresh. She knew it would be critical to reassess the company’s strategic focus for generics, but the GM of the relevant business unit was too busy managing two global businesses to do the work. A few months before the deadline, with key decisions about the structure of the business pending, both executives realized they needed help—without the cost or complexity of a Big Three consulting firm.

Within days, Business Talent Group delivered an experienced life science strategist who had a PhD in Biological Chemistry, served as an Engagement Manager at McKinsey, and held executive positions at Monsanto and other pharma companies. By the end of the week, he’d started his analysis, with a global project kick-off in Thailand the following Tuesday. Four months later, the project was complete, and his work was ready to be integrated into the strategy team’s other assessments.


Previous Article
Building a Direct-to-Consumer Sales Channel
Building a Direct-to-Consumer Sales Channel

The transformation group at a F200 pharma company was piloting a direct-to-consumer channel for a dozen of ...

Next Article
Machine Learning Market Landscape
Machine Learning Market Landscape

The VP of Strategy at a global financial information company was assessing opportunities in the promising b...


Talk with BTG to learn more about our on-demand talent.

First Name
Last Name
I would like to receive the latest expert insights and news from Business Talent Group.
By registering, you agree to the processing of your personal data by Business Talent Group as described in the Privacy Statement.
View our Privacy Policy and Cookie Policy
Thank you! We will be in touch shortly.
Error - something went wrong!